Table 2.
Clinical variables of the analyzed population according to patients undergoing IHDVC categorization.
| Variable | Patients Undergoing IHDVC (n = 104) |
Patients Not Undergoing IHDVC (n = 42) |
p |
|---|---|---|---|
| Age § | 64 (53–76) | 64 (56–76) | 0.8086 |
| Men (%) | 61.5 | 54.8 | 0.4500 |
| Pre-existing comorbidities (%) | 79.6 | 82.5 | 0.6960 |
| Hypertension (%) | 71.8 | 65.0 | 0.4230 |
| Obesity (BMI ≥ 30 Kg/m2) (%) | 39.2 | 45.0 | 0.5282 |
| Diabetes mellitus (%) | 35.9 | 35.0 | 0.9177 |
| Chronic ischemic heart disease or Chronic cerebrovascular disease (%) |
29.1 | 30.0 | 0.9180 |
| Chronic renal failure (%) | 13.6 | 17.5 | 0.5535 |
| Neoplasm (active or previous) (%) | 10.7 | 12.5 | 0.7566 |
| Oxygen support at admission: None (%) | 39.4 | 30.9 | 0.3372 |
| Oxygen support at admission: Nose cannulas (%) | 11.5 | 7.1 | 0.4284 |
| Oxygen support at admission: Venturi mask (%) | 23.1 | 30.9 | 0.3220 |
| Oxygen support at admission: CPAP (%) | 12.5 | 23.8 | 0.0895 |
| Oxygen support at admission: NIV S/T (%) | 12.5 | 7.1 | 0.3482 |
| Hospitalization days § | 18 (13–27) | 24 (13–31) | 0.1596 |
| Admission to intensive care/ICU (%) | 9.7 | 5.0 | 0.3620 |
| Death (%) | 8.6 | 14.3 | 0.3103 |
§ Data reported as medians (Q1–Q3).